AccuStem Sciences is set to launch the microRNA Signature Classifier (MSC) blood test for the US lung cancer screening programmes. The company aims to broaden the test's use to the 15 million ...
SAN ANTONIO, April 01, 2026--bioAffinity Technologies’ CyPath Lung Sales Surged 146% Year-Over-Year in Q1 2026, gaining ...
A revolutionary AI-powered diagnostic test for chronic obstructive pulmonary disease (COPD) is set to be introduced in GP surgeries across England from 14 April, offering a faster and more accurate ...
In this case study, CyPath® Lung “Unlikely Malignancy” result supported physician’s decision to wait before ordering an invasive lung biopsy In a clinical study, noninvasive CyPath® Lung test ...
Thousands of people in Hampshire and Yorkshire will be invited to undergo the new iDx Lung diagnostic tests during the next three years. Did you know with a Plus subscription to Shropshire Star you ...
Lung cancer accounts for 1 in 5 cancer-related deaths in the United States. While doctors say lung cancer is often treatable if caught early, millions of Americans who should be getting screened for ...
When doctors review diagnostic medical scans for lung cancer, they sometimes spot abnormalities unrelated to the lungs. New ...
Lung cancer is the leading cause of cancer deaths worldwide, and early detection is key: there is a 12-fold increase in five-year survivorship between those detected at stage one versus stage four.
A UIS epidemiologist is leading a community effort to reduce lung cancer risk through radon education, free test kits and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results